Company Filing History:
Years Active: 2017
Title: Innovations of Fang Bai in Pharmaceutical Chemistry
Introduction
Fang Bai is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases.
Latest Patents
Fang Bai holds a patent for a pteridine ketone derivative, which serves as an inhibitor for EGFR, BLK, and FLT3. This innovative compound is designed to be used in pharmaceutical compositions aimed at treating diseases mediated by these targets. The patent outlines the compound's formula and its applications in medicine, showcasing its potential in therapeutic settings.
Career Highlights
Fang Bai is affiliated with the East China University of Science and Technology, where he engages in research and development activities. His work focuses on creating effective pharmaceutical solutions that address critical health issues.
Collaborations
Fang Bai collaborates with esteemed colleagues, including Honglin Li and Yufang Xu, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work in the field.
Conclusion
Fang Bai's innovative contributions to pharmaceutical chemistry, particularly through his patent on pteridine ketone derivatives, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments.